← Every applicant

Teva Pharms USA FDA Approvals

29 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
TOFACITINIB CITRATENew drugAug 17, 2026TABLET, EXTENDED RELEASE, ORAL
ELTROMBOPAG OLAMINENew drugJul 13, 2026TABLET, ORAL
LINAGLIPTINNew drugMay 27, 2026TABLET, ORAL
DAPAGLIFLOZINNew drugApr 6, 2026TABLET, ORAL
FERRIC CITRATENew drugMar 11, 2026TABLET, ORAL
DASATINIBNew drugAug 27, 2025TABLET, ORAL
TERIPARATIDENew drugNov 16, 2023SOLUTION, SUBCUTANEOUS
ABIRATERONE ACETATENew drugJan 26, 2023TABLET, ORAL
PENCICLOVIRNew drugNov 9, 2022CREAM, TOPICAL
DEFERASIROXNew drugSep 23, 2022TABLET, FOR SUSPENSION, ORAL
ABIRATERONE ACETATENew drugJun 24, 2022TABLET, ORAL
MESALAMINENew drugMay 6, 2022CAPSULE, EXTENDED RELEASE, ORAL
POMALIDOMIDENew drugMay 4, 2022CAPSULE, ORAL
ZILEUTONNew drugMay 3, 2022TABLET, EXTENDED RELEASE, ORAL
BORTEZOMIBNew drugMay 2, 2022INJECTABLE, INTRAVENOUS, SUBCUTANEOUS
DOFETILIDENew drugApr 15, 2022CAPSULE, ORAL
IVERMECTINNew drugMar 21, 2022LOTION, TOPICAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugJan 31, 2022CAPSULE, EXTENDED RELEASE, ORAL
PIRFENIDONENew drugJan 25, 2022TABLET, ORAL
MYCOPHENOLATE MOFETILNew drugJan 25, 2022FOR SUSPENSION, ORAL
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATENew drugDec 13, 2021POWDER, INHALATION
SUNITINIB MALATENew drugNov 30, 2021CAPSULE, ORAL
DEFERASIROXNew drugNov 19, 2021GRANULE, ORAL
FINGOLIMOD HYDROCHLORIDENew drugNov 12, 2021CAPSULE, ORAL
ARFORMOTEROL TARTRATENew drugNov 9, 2021SOLUTION, INHALATION
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDENew drugNov 2, 2021CAPSULE, ORAL
IBUPROFEN AND FAMOTIDINENew drugOct 29, 2021TABLET, ORAL
ONSURANew drugAug 25, 2021FILM, EXTENDED RELEASE, TRANSDERMAL
BEXAROTENENew drugJan 14, 2021CAPSULE, ORAL

Related datasets